Skip to main content
Clinical Trials/ISRCTN81718275
ISRCTN81718275
Completed
N/A

A randomised controlled trial to examine the effects of calcimimetic therapy on bone and cardiovascular health in end-stage renal disease

Salford Royal NHS Foundation Trust (UK)0 sites40 target enrollmentJuly 31, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Salford Royal NHS Foundation Trust (UK)
Enrollment
40
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2008
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Salford Royal NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18\-75 at recruitment, both male and female
  • 2\. On haemodialysis for \>90 days
  • 3\. Parathyroid hormone (PTH) \>\=300 pg/ml
  • 4\. Corrected calcium \>\=2\.1 mmol/l

Exclusion Criteria

  • 1\. Atrial fibrillation
  • 2\. Any contra\-indications to magnetic resonance (MR) scan or ability to cooperate with scan
  • 3\. Any factors which will influence computed tomography (CT) scan e.g. artificial heart valves, previous sternotomy wires, stents
  • 4\. Contra\-indication to cinacalcet e.g., pregnant, breast feeding, known reaction
  • 5\. Moderate to severe liver disease (alanine transaminase \[ALT] \>3x normal)
  • 6\. Have a poor record of compliance with medication
  • 7\. Have participated in a study involving an investigational drug during the 30 days prior to the first visit
  • 8\. Be involved in any other research study which exposes the patient to radiation above that of normal clinical practice

Outcomes

Primary Outcomes

Not specified

Similar Trials